Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-24

FDA Approved: NIFEDIPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for nifedipine by Upsher-Smith Laboratories, LLC, facilitating a labeling/strength update for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

SUPPL AP for NIFEDIPINE (NIFEDIPINE)